Advances in the diagnosis and treatment of pediatric acute lymphoblastic leukemia

H Inaba, CH Pui - Journal of clinical medicine, 2021 - mdpi.com
The outcomes of pediatric acute lymphoblastic leukemia (ALL) have improved remarkably
during the last five decades. Such improvements were made possible by the incorporation of …

Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies

A Zhao, H Zhou, J Yang, M Li, T Niu - Signal Transduction and Targeted …, 2023 - nature.com
Hematologic malignancies are one of the most common cancers, and the incidence has
been rising in recent decades. The clinical and molecular features of hematologic …

The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities

TH Tran, SP Hunger - Seminars in cancer biology, 2022 - Elsevier
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer and constitutes
approximately 25% of cancer diagnoses among children under the age of 15 (Howlader et …

Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma …

L Pommert, ES Schafer, J Malvar… - American journal of …, 2022 - Wiley Online Library
Survival outcomes for relapsed/refractory pediatric acute myeloid leukemia (R/R AML)
remain dismal. Epigenetic changes can result in gene expression alterations which are …

Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects

J Ru, Y Wang, Z Li, J Wang, C Ren, J Zhang - European Journal of …, 2023 - Elsevier
Histone deacetylases (HDACs) catalyze the hydrolysis of acetyl-l-lysine side chains in
histones and non-histones, which are key to epigenetic regulation in humans. Targeting …

The DNA methylation landscape of hematological malignancies: an update

P Blecua, L Martinez‐Verbo, M Esteller - Molecular Oncology, 2020 - Wiley Online Library
The rapid advances in high‐throughput sequencing technologies have made it more evident
that epigenetic modifications orchestrate a plethora of complex biological processes. During …

Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?

MR Farani, M Sarlak, A Gholami, M Azaraian… - … -Research and Practice, 2023 - Elsevier
Epigenetics is the study of heritable changes in gene expression or function without altering
the DNA sequence. Important factors are part of epigenetic events, such as methylation …

Targeting epigenetic regulation for cancer therapy using small molecule inhibitors

A Kumar, L Emdad, PB Fisher, SK Das - Advances in Cancer Research, 2023 - Elsevier
Cancer cells display pervasive changes in DNA methylation, disrupted patterns of histone
posttranslational modification, chromatin composition or organization and regulatory …

Genetic and epigenetic targeting therapy for pediatric acute lymphoblastic leukemia

H Xu, H Yu, R **, X Wu, H Chen - Cells, 2021 - mdpi.com
Acute lymphoblastic leukemia is the most common malignancy in children and is
characterized by numerous genetic and epigenetic abnormalities. Epigenetic mechanisms …

Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma

S Demir, N Razizadeh, E Indersie… - Hepatology …, 2024 - journals.lww.com
Background: As the variable clinical outcome of patients with hepatoblastoma (HB) cannot
be explained by genetics alone, the identification of drugs with the potential to effectively …